【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Metastatic Ovarian Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Metastatic Ovarian Cancer to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Metastatic Ovarian Cancer 24
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Metastatic Ovarian Cancer Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Metastatic Ovarian Cancer 32
Jan 09, 2014: Synta Announces Launch of GANNET53, a Randomized, pan-European Study of Ganetespib in p53 Mutant, Metastatic Ovarian Cancer 32
Mar 18, 2013: Merrimack Pharma Completes Enrollment In Phase II Study Of MM-121 In Combination With Paclitaxel In Patients With Platinum-resistant Or Refractory Advanced Ovarian Cancers 32
Mar 06, 2013: Ziopharm Oncology Announces Initiation Of Indiana University-sponsored Phase II Study Of Palifosfamide In Recurrent And Incurable Germ Cell Tumors 33
Dec 28, 2011: Researchers Reveal Targeted Therapy Extends Progression-Free Survival Of Patients With Advanced Ovarian Cancer 33
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
MolMed S.p.A. 36
Clinical Trial Overview of MolMed S.p.A. 36
Isis Pharmaceuticals, Inc. 37
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 37
E. Merck KG 38
Clinical Trial Overview of E. Merck KG 38
Daiichi Sankyo Company, Limited 39
Clinical Trial Overview of Daiichi Sankyo Company, Limited 39
AbbVie Inc. 40
Clinical Trial Overview of AbbVie Inc. 40
Eli Lilly and Company 41
Clinical Trial Overview of Eli Lilly and Company 41
Cell Therapeutics, Inc. 42
Clinical Trial Overview of Cell Therapeutics, Inc. 42
California Stem Cell, Inc. 43
Clinical Trial Overview of California Stem Cell, Inc. 43
Bristol-Myers Squibb Company 44
Clinical Trial Overview of Bristol-Myers Squibb Company 44
Clinical Trial Overview of Top Institutes / Government 45
National Cancer Institute 45
Clinical Trial Overview of National Cancer Institute 45
NCIC Clinical Trials Group 47
Clinical Trial Overview of NCIC Clinical Trials Group 47
University of Washington 48
Clinical Trial Overview of University of Washington 48
The University of Texas Health Science Center at San Antonio 49
Clinical Trial Overview of The University of Texas Health Science Center at San Antonio 49
Rutgers, The State University of New Jersey 50
Clinical Trial Overview of Rutgers, The State University of New Jersey 50
European Organization for Research and Treatment of Cancer 51
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 51
Albert Einstein College of Medicine of Yeshiva University 52
Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University 52
Karolinska Institutet 53
Clinical Trial Overview of Karolinska Institutet 53
Weill Cornell Medical College 54
Clinical Trial Overview of Weill Cornell Medical College 54
Five Key Clinical Profiles 55
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 82
【レポート販売概要】
■ タイトル：転移性卵巣癌：グローバル臨床試験レビュー（2014年上半期）■ 英文：Metastatic Ovarian Cancer Global Clinical Trials Review, H1, 2014
■ 発行日：2014年4月15日
■ 調査会社：GlobalData
■ 商品コード：GDHC2073CTIDB
■ 調査対象地域：グローバル
- 空気噴霧器の世界市場分析：タイプ別（通気、呼吸作動型）、地域別（北米（アメリカ･カナダ）、ヨーロッパ（英国＆ドイツ）、アジア太平洋（日本、中国･インド）、ラテンアメリカ（ブラジル･メキシコ）、MEA）、セグメント予測、2014-2025The global pneumatic nebulizers market was valued at USD 490.6 million in 2015 and is expected to reach a value of USD 893.9 million by 2025. The expansion is attributed to the increasing geriatric population base along with the growing need for home healthcare portable devices. The introduction of new systems featuring aerosol drug delivery technology with minimal drug wastage is expected to driv …
- NuStar Energy L.P.：石油・ガスバリューチェーン分析レポート2013NuStar Energy L.P. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "NuStar Energy L.P." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “NuStar Energy L.P.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines t …
- Rituxan (Systemic Lupus Erythematosus and Lupus Nephritis)：市場予測と分析（～2022）Rituxan (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022 Summary Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe manifestations includes renal (kidney) involvemen …
- 皮膚糸状菌爪真菌症（DO）：米国（医薬品市場予測及び分析～2022）PharmaPoint: Dermatophytic Onychomycosis (DO) - US Drug Forecast and Market Analysis to 2022 Summary Dermatophytic onychomycosis (DO) is characterized as being a fungal infection of the nail. Infection can involve the nail unit (nail matrix, nail bed, or nail plate). DO isn’t considered life-threatening, however can cause patients to experience discomfort, pain, and may cause physical and occupati …
- 抗体薬物複合体（ADC）の世界市場2015：パイプライン分析、技術動向、競争状況Summary: DelveInsight’s Antibody-Drug Conjugate: Global Market and Pipeline Outlook, 2015, report provides the information across the ADCs drug value chain. The Report provides the marketed and pipeline scenario of the ADCs. The Report has covered the 264 Antibody-drug conjugates profile which gives core information of the targets, mechanism of action, development partner, Technology partner, mono …
- 局所ドラッグデリバリ（局所薬物送達）の世界市場予測（～2021）The topical drug delivery market is expected to reach USD 125.88 Billion by 2021 from USD 92.40 Billion in 2016 at a CAGR of 6.4% during the forecast period. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes. The market is segmented based on product type, route of administration, facility of us …
- 世界の硝子体タンポナーデ市場2015The Global Vitreous Tamponades Industry Report 2015 is a professional and in-depth study on the current state of the Vitreous Tamponades industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Vitreous Tamponades market analysis is provided for the international markets including development trends, compe …
- BP p.l.c.：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012BP p.l.c. Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary BP p.l.c. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational dat …
- 静脈イルミネーターの世界市場分析：技術別（透照法、赤外線技術、超音波）、用途別（静脈内アクセス、採血）、エンドユーザー別（病院、リハビリ施設、献血キャンプ、学術機関）、地域別（アメリカ、カナダ、ドイツ、英国、中国、インド、南アフリカ、サウジアラビア、ブラジル、メキシコ）、セグメント予測The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient sa …
- ハロゲン市場：韓国This report is a comprehensive research of halogens market in South Korea. The report starts with giving brief country profile for South Korea, including general information and main economic indicators. Further, the report provides in-depth analyses halogens market in the country. It identifies key market players, including major producers, wholesalers and distributing companies. The third chapte …
- 2014年戦略提言：日本の臨床化学・免疫診断市場Complete report $7,600. DataPack (test volumes, sales forecasts, supplier shares) $4,900.“2014 Strategies for the Japanese Clinical Chemistry and Immunodiagnostic Market” is a new strategic analysis of major business opportunities emerging in the Japanese clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in th …
- ユーザー・エンティティ行動分析（UEBA）の世界市場予測（～2021）The global user and entity behavior analytics market is estimated to grow from USD 131.7 Million in 2016 to USD 908.3 Million by 2021, at a CAGR of 47.1% during the forecast period. The global user and entity behavior analytics market is driven by increasing cyber threats posed by insiders in organizations and incapability of traditional security tools to identify such insider threats. Moreover, l …
- 有機太陽電池の市場分析：Analyzing Organic PhotovoltaicsThe Sun, believed by the mankind to be just a mere centerpiece of the solar system in which we live is in reality not just a unit but an entire symphonic system which was in place much before the first humans ever walked on planet earth. This system which has been the primary energy source for origin of life on earth is in fact very well adequately positioned by nature to fulfill the needs of ener …
- イーサネット・コントローラーの世界市場予測（～2023年）：イーサネット、ファストイーサネット、ギガビットイーサネット“Growing demand for high-performance applications and integration of advanced features are fostering the growth of the Ethernet controller market” The Ethernet controller market is expected to be worth USD 11.89 billion by 2023, growing at a CAGR of 6.22% between 2017 and 2023. The growth of this market is propelled by the growing demand for high-performance applications, integration of advanced f …
- セルフモニタリング血糖検査用ストリップの世界市場2017-2021About Self-Monitoring Blood Glucose StripsThe blood glucose strips market is a part of the SMBG market. The global SMBG devices market is organized and is expected to grow rapidly with the increase in incidence of diabetes across the globe. Vendors are offering SMBG devices that are safe, portable, accurate, and require low power consumption. The availability of innovative and advanced SMBG device …
